- Home
- Publications
- Publication Search
- Publication Details
Title
Immunotherapy biomarkers 2016: overcoming the barriers
Authors
Keywords
Biomarkers, Immunotherapy, Immune monitoring, High throughput, Baseline measures, Tumor microenvironment
Journal
Journal for ImmunoTherapy of Cancer
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-03-07
DOI
10.1186/s40425-017-0225-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic evaluation of immune regulation and modulation
- (2017) David F. Stroncek et al. Journal for ImmunoTherapy of Cancer
- Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non–Small-Cell Lung Cancer
- (2016) Elisabeth Brambilla et al. JOURNAL OF CLINICAL ONCOLOGY
- Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease
- (2016) Jennifer N. Brudno et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
- (2016) Alena Gros et al. NATURE MEDICINE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutant KRAS Conversion of Conventional T Cells into Regulatory T Cells
- (2016) S. Zdanov et al. Cancer Immunology Research
- Immune monitoring technology primer: whole exome sequencing for neoantigen discovery and precision oncology
- (2016) Pia Kvistborg et al. Journal for ImmunoTherapy of Cancer
- Immune monitoring technology primer: immunoprofiling of antigen-stimulated blood
- (2016) Laura Rosa Brunet et al. Journal for ImmunoTherapy of Cancer
- Biomarkers immune monitoring technology primer: Immunoscore® Colon
- (2016) Fabienne Hermitte Journal for ImmunoTherapy of Cancer
- Multiplexed tissue biomarker imaging
- (2016) Edward C. Stack et al. Journal for ImmunoTherapy of Cancer
- Novel technologies and emerging biomarkers for personalized cancer immunotherapy
- (2016) Jianda Yuan et al. Journal for ImmunoTherapy of Cancer
- Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations
- (2016) Kevin K. Dobbin et al. Journal for ImmunoTherapy of Cancer
- Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation
- (2016) Giuseppe V. Masucci et al. Journal for ImmunoTherapy of Cancer
- Immune Monitoring Technology Primer: protein microarray (‘seromics’)
- (2016) Jianda Yuan et al. Journal for ImmunoTherapy of Cancer
- Immune Profiles to Predict Response to Desensitization Therapy in Highly HLA-Sensitized Kidney Transplant Candidates
- (2016) Julie M. Yabu et al. PLoS One
- Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
- (2015) James N. Kochenderfer et al. JOURNAL OF CLINICAL ONCOLOGY
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Guidelines for the automated evaluation of Elispot assays
- (2015) Sylvia Janetzki et al. Nature Protocols
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
- (2015) Mihaela Angelova et al. GENOME BIOLOGY
- Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury
- (2015) C. R. Heery et al. Cancer Immunology Research
- Immunological markers and clinical outcome of advanced melanoma patients receiving ipilimumab plus fotemustine in the NIBIT-M1 study
- (2015) Cristina Maccalli et al. OncoImmunology
- Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer
- (2015) Christopher R. Heery et al. JAMA Oncology
- Immune monitoring technology primer: clinical validation for predictive markers
- (2015) Kevin K. Dobbin Journal for ImmunoTherapy of Cancer
- Immune monitoring technology primer: flow and mass cytometry
- (2015) Holden T. Maecker et al. Journal for ImmunoTherapy of Cancer
- Immune monitoring technology primer: Single Cell Network Profiling (SCNP)
- (2015) Rachael E. Hawtin et al. Journal for ImmunoTherapy of Cancer
- Immune monitoring technology primer: immunosequencing
- (2015) Ilan Kirsch Journal for ImmunoTherapy of Cancer
- Immune monitoring technology primer: the enzyme-linked immunospot (Elispot) and Fluorospot assay
- (2015) Sylvia Janetzki Journal for ImmunoTherapy of Cancer
- Quantitative real-time PCR assisted cell counting (qPACC) for epigenetic - based immune cell quantification in blood and tissue
- (2015) Thomas Oliver Kleen et al. Journal for ImmunoTherapy of Cancer
- Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma
- (2015) Zipei Feng et al. Journal for ImmunoTherapy of Cancer
- nCounter® PanCancer Immune Profiling Panel (NanoString Technologies, Inc., Seattle, WA)
- (2015) Alessandra Cesano Journal for ImmunoTherapy of Cancer
- Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer
- (2014) Claire Germain et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study
- (2014) A. M. Di Giacomo et al. ANNALS OF ONCOLOGY
- Monitoring the immune competence of cancer patients to predict outcome
- (2014) Serena Chang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
- (2014) M.-G. Anitei et al. CLINICAL CANCER RESEARCH
- Detection of Minimal Residual Disease in B Lymphoblastic Leukemia by High-Throughput Sequencing of IGH
- (2014) D. Wu et al. CLINICAL CANCER RESEARCH
- The immunological and clinical effects of mutated ras peptide vaccine in combination with IL-2, GM-CSF, or both in patients with solid tumors
- (2014) Osama E Rahma et al. Journal of Translational Medicine
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- mTOR inhibition improves immune function in the elderly
- (2014) J. B. Mannick et al. Science Translational Medicine
- Integrating and mining diverse data in human immunological studies
- (2014) Janet C Siebert et al. Bioanalysis
- Emerging Understanding of Multiscale Tumor Heterogeneity
- (2014) Michael J. Gerdes et al. Frontiers in Oncology
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
- (2013) Nienke van Rooij et al. JOURNAL OF CLINICAL ONCOLOGY
- Spatial organization of dendritic cells within tumor draining lymph nodes impacts clinical outcome in breast cancer patients
- (2013) Andrew Y Chang et al. Journal of Translational Medicine
- Immune Impact Induced by PROSTVAC (PSA-TRICOM), a Therapeutic Vaccine for Prostate Cancer
- (2013) J. L. Gulley et al. Cancer Immunology Research
- The immune score as a new possible approach for the classification of cancer
- (2012) Jérôme Galon et al. Journal of Translational Medicine
- Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial
- (2012) Anna Maria Di Giacomo et al. LANCET ONCOLOGY
- Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
- (2012) Steffen Walter et al. NATURE MEDICINE
- A deep profiler's guide to cytometry
- (2012) Sean C. Bendall et al. TRENDS IN IMMUNOLOGY
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- Epitope spreading contributes to effective immunotherapy in metastatic melanoma patients
- (2011) Nicola Hardwick et al. Immunotherapy
- Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
- (2011) J. Yuan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Establishment of Antitumor Memory in Humans Using in Vitro-Educated CD8+ T Cells
- (2011) M. O. Butler et al. Science Translational Medicine
- Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
- (2010) Laurence Amiot et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society
- (2010) R. Mallone et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- “MIATA”—Minimal Information about T Cell Assays
- (2009) Sylvia Janetzki et al. IMMUNITY
- Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer
- (2009) Mary L. Disis et al. JOURNAL OF CLINICAL ONCOLOGY
- In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
- (2009) Franck Pagès et al. JOURNAL OF CLINICAL ONCOLOGY
- mTOR regulates memory CD8 T-cell differentiation
- (2009) Koichi Araki et al. NATURE
- Validation of Analytic Methods for Biomarkers Used in Drug Development
- (2008) C. H. Chau et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now